This is a ready-to-use quality manual, the tier 1 document that describes the QMS itself rather than any single task. It does not tell anyone how to run an autoclave; it describes the system, its scope, and where to find the procedures that govern each part of it. Replace every <<FILL: ...>> placeholder with your own specifics, set your document number and dates, and route it through top management and QA approval. A worked filled specimen follows the template. This content is educational reference to adapt, not a compliance guarantee; verify each cited regulation against the current source before you rely on it.
Document control header
| Field | Entry |
|---|---|
| Document title | Quality Manual, <<FILL: COMPANY / SITE NAME>> |
| Document number | <<FILL: QM-ID, e.g. QM-001>> |
| Version | <<FILL: version, e.g. 1.0>> |
| Effective date | <<FILL: effective date>> |
| Supersedes | <<FILL: prior version or "New">> |
| Document owner | <<FILL: role, e.g. Head of Quality>> |
| Review cycle | <<FILL: e.g. annually, or on QMS structural change>> |
1. Scope
<<FILL: COMPANY NAME>>’s quality management system, described in this manual, covers <<FILL: the sites, products, and activities in scope, e.g. drug substance and drug product manufacturing, testing, packaging, and release at [site]>>. This manual applies to <<FILL: which functions and sites it binds>>.
1.1 Exclusions
The following activities are outside the scope of this QMS, with the stated justification: <<FILL: list any genuinely excluded activity and why, e.g. "clinical trial conduct, governed under a separate GCP quality system," or state "none" if the QMS covers all site activities>>. An exclusion claimed without a stated reason is not defensible at inspection.
2. Quality policy
<<FILL: COMPANY NAME>> is committed to meeting applicable regulatory, customer, and safety requirements, to the continual improvement of the quality management system, and to a framework for setting and reviewing quality objectives. The full quality policy is <<FILL: reproduced below, or referenced by document number>>.
<<FILL: quality policy statement text, signed and dated by top management>>
3. Organization
3.1 Organizational structure
<<FILL: describe or reference the org chart showing how the quality unit sits relative to operations>>. The quality unit is organizationally independent of production and other operational functions with which it interacts, so that quality decisions (release, rejection, deviation disposition) are made without pressure from production schedules or commercial targets.
3.2 Key roles
| Role | Responsibility |
|---|---|
<<FILL: e.g. Head of Quality / QA Director>> | Owns the QMS, this manual, and the release decision authority |
<<FILL: e.g. Site Head>> | Provides resources for the QMS and participates in management review |
<<FILL: e.g. Qualified Person / Responsible Person>> | <<FILL: batch certification / release authority where applicable>> |
<<FILL: process owners by function>> | Own their tier 2 procedures and the records their processes generate |
4. QMS description
4.1 Core QMS processes
This QMS is built from the following interacting processes, consistent with a pharmaceutical quality system model such as ICH Q10:
| Process | Purpose | Governing procedure |
|---|---|---|
| Document control | Control creation, approval, and retirement of documents | <<FILL: SOP-ID>> |
| Change control | Assess and control changes to validated systems, processes, and specifications | <<FILL: SOP-ID>> |
| Deviation management | Investigate and disposition departures from procedure or specification | <<FILL: SOP-ID>> |
| CAPA | Correct and prevent recurrence of quality problems | <<FILL: SOP-ID>> |
| Complaint handling | Receive, investigate, and respond to product complaints | <<FILL: SOP-ID>> |
| Supplier / vendor qualification | Assess and approve suppliers of GxP-relevant materials and services | <<FILL: SOP-ID>> |
| Training | Qualify personnel to perform their assigned GxP tasks | <<FILL: SOP-ID>> |
| Internal audit / self-inspection | Independently verify the QMS is operating as designed | <<FILL: SOP-ID>> |
| Management review | Top management reviews QMS performance and resources it | <<FILL: SOP-ID>> |
| Validation and qualification | Establish and maintain the validated state of systems and equipment | <<FILL: SOP-ID>> |
| Product release / disposition | Authorize release of product, batches, or results | <<FILL: SOP-ID>> |
| Records management | Control and retain GxP records | <<FILL: SOP-ID>> |
Add or remove rows for processes specific to your operation (stability program, environmental monitoring, pharmacovigilance interface for a marketing authorization holder, and so on).
4.2 How the processes interact
<<FILL: a short description or a process-interaction diagram showing, for example, that a deviation may trigger a CAPA, that a CAPA may trigger a change control, and that a change control may trigger validation and training activities>>. State plainly, in your own words, how the processes feed one another; a reviewer is checking that you understand the system as connected, not as a list of unrelated procedures.
5. Documentation structure
This QMS documentation is organized as a four-tier hierarchy: this quality manual and the quality policy at the top, policies and quality system procedures below it, SOPs and work instructions below that, and records and forms as the base layer of executed evidence. Documents at a lower tier never contradict a higher tier. The document control system that maintains this hierarchy, including numbering, versioning, approval, and retirement, is governed by <<FILL: SOP-ID for document control>>.
6. Requirement to procedure cross-reference
| Requirement | Reference standard / regulation | Governing procedure |
|---|---|---|
| Document control | <<FILL: e.g. EU GMP Chapter 4; 21 CFR 211.180/211.100; ICH Q10>> | <<FILL: SOP-ID>> |
| Control of records | <<FILL>> | <<FILL>> |
| Change control | <<FILL>> | <<FILL>> |
| Deviation management | <<FILL>> | <<FILL>> |
| CAPA | <<FILL>> | <<FILL>> |
| Complaint handling | <<FILL>> | <<FILL>> |
| Supplier qualification | <<FILL>> | <<FILL>> |
| Internal audit | <<FILL>> | <<FILL>> |
| Management review | <<FILL>> | <<FILL>> |
| Validation and qualification | <<FILL>> | <<FILL>> |
| Product release | <<FILL>> | <<FILL>> |
Add every requirement genuinely applicable to your operation. This table is the single artifact inspectors most often ask to see first, because it proves the company knows which requirements apply and has a named, current procedure for each.
7. Management commitment
Top management commits resources to maintain the QMS, participates in management review at the frequency defined in <<FILL: SOP-ID for management review>>, and reviews this manual <<FILL: on the stated cycle>> or when the QMS structure changes materially (new site, new product type, reorganized quality unit).
8. Revision history
| Version | Date | Author | Summary of change |
|---|---|---|---|
<<FILL: 1.0>> | <<FILL: date>> | <<FILL: author>> | Initial issue. |
9. Approvals
| Role | Name | Signature | Date |
|---|---|---|---|
| Author | <<FILL>> | ||
| Reviewer (QA) | <<FILL>> | ||
| Approver (Top Management) | <<FILL>> |
Filled specimen
The following shows the scope, key roles, and cross-reference sections completed for an example single-site biologics manufacturer, so you can see the level of detail an inspector expects. The company and numbers are illustrative; replace them with your own.
| Section | Entry |
|---|---|
| Scope | Drug substance manufacturing, fill-finish, QC testing, and release at the Holliston site; excludes clinical trial conduct, governed under a separate GCP quality system referenced in section 1.1 |
| Head of Quality | A. Ferreira, accountable for the QMS and release decision authority |
| Core processes with procedures | 12 processes listed, each with a current, approved governing SOP; none marked “in development” |
| Cross-reference sample row | Document control: EU GMP Chapter 4, 21 CFR 211.180/211.100, ICH Q10, governed by SOP-QA-001 |
| Review cycle | Annual, last reviewed 2026-02-01, next due 2027-02-01 |
An inspector who opens this manual can immediately see the scope, who is accountable, which twelve processes make up the system, and exactly which procedure governs each regulatory requirement, without having to ask a follow-up question to locate any of it.
Common inspection findings this template prevents
- A quality manual that is a copy-paste of the ISO or GMP text with no description of how this specific company actually works; inspectors notice generic, content-free manuals immediately.
- A quality policy that promises continual improvement with no traceable objectives and no evidence of review.
- A scope exclusion claimed with no stated justification.
- The manual referencing procedures that no longer exist or have been renumbered, breaking the chain from commitment to procedure.
- No cross-reference table, so the inspector cannot quickly confirm the company has mapped its obligations to named, current procedures.
How to adapt this template
- Set the company or site name, document number, and review cycle in the header.
- Write section 1 in your own words describing what your operation actually does; do not leave it as a restatement of a standard’s clause.
- Populate section 4.1 with your actual QMS processes and their current governing procedure numbers; delete rows that do not apply and add ones that do (pharmacovigilance, stability, environmental monitoring, as relevant).
- Build the cross-reference table in section 6 completely before issue; it is the artifact most likely to be checked first.
- Confirm every regulation cited against the current published version before issue.